Progress report on new antiepileptic drugs: a summary of the Third Eilat Conference

Epilepsy Research
M BialerE Perucca

Abstract

The Third Eilat Conference on New Antiepileptic Drugs was held at the Royal Beach Hotel from May 27 to May 30, 1996. Epileptologists and scientists from 20 countries attended the conference, which was held to discuss critical issues in drug development, new antiepileptic drugs (AEDs) in development, progress reports and recent findings of newly marketed AEDs, the use of AEDs in special populations and their utilization in non-epileptic disorders. Over the last seven years, six new AEDs have been introduced worldwide and new information on their safety and efficacy has become available. These include felbamate, gabapentin, lamotrigine, oxcarbazepine, topiramate and vigabatrin. Drugs in development include those at an advanced stage, such as remacemide and tiagabine, as well as those just entering clinical trials, such as rufinamide (CGP 331010) and levetiracetam (ucb LO59). The following is a summary of the presentations for drugs in development and recent findings on newly marketed drugs.

References

Sep 15, 1995·Annals of the New York Academy of Sciences·G C PalmerF Willett
Aug 1, 1994·Neurology·M D PriviteraJ H Wood
Jun 1, 1996·Neurology·T R BrowneM A Eldon
Jan 1, 1995·Epilepsia·J A Messenheimer
May 15, 1996·European Journal of Pharmacology·C ToberR Bartsch
Jan 3, 2007·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·James W WhelessStephen D Collins

❮ Previous
Next ❯

Citations

Apr 17, 1998·European Journal of Pharmacology·W Löscher
Oct 28, 1998·Journal of Psychiatric Research·A ErfurthJ Walden
Jun 25, 1999·Progress in Neurobiology·P GareriG De Sarro
Aug 23, 2001·Pediatric Neurology·F M BesagA D Dean
Dec 29, 2000·Bioorganic & Medicinal Chemistry·E Estrada, A Peña
Feb 1, 2007·Neuropsychiatric Disease and Treatment·Gerhard Kluger, Bettina Bauer
Oct 16, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·M Bialer
Nov 4, 2000·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·G J SillsM J Brodie
Mar 6, 2013·Journal of Food Science·Farid MenaaBouzid Menaa
Jun 24, 2004·Bioorganic & Medicinal Chemistry·Silvina M TassoGuillermina L Estiú

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.